- Home
- Publications
- Publication Search
- Publication Details
Title
PET-CT in Clinical Adult Oncology: I. Hematologic Malignancies
Authors
Keywords
-
Journal
Cancers
Volume 14, Issue 23, Pages 5941
Publisher
MDPI AG
Online
2022-12-01
DOI
10.3390/cancers14235941
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Role of Radiomics-Based Baseline PET/CT Imaging in Lymphoma: Diagnosis, Prognosis, and Response Assessment
- (2022) Han Jiang et al. MOLECULAR IMAGING AND BIOLOGY
- Comparison of FDG PET/CT and Bone Marrow Biopsy Results in Patients with Diffuse Large B Cell Lymphoma with Subgroup Analysis of PET Radiomics
- (2022) Eun Ji Han et al. Diagnostics
- Second Revision of the International Staging System (R2-ISS) for Overall Survival in Multiple Myeloma: A European Myeloma Network (EMN) Report Within the HARMONY Project
- (2022) Mattia D'Agostino et al. JOURNAL OF CLINICAL ONCOLOGY
- Prognostic Value of Heterogeneity Index Derived from Baseline 18F-FDG PET/CT in Mantle Cell Lymphoma
- (2022) Fei Liu et al. Frontiers in Oncology
- Overall Survival with Brentuximab Vedotin in Stage III or IV Hodgkin’s Lymphoma
- (2022) Stephen M. Ansell et al. NEW ENGLAND JOURNAL OF MEDICINE
- PET/CT in Multiple Myeloma: Beyond FDG
- (2021) Federica Matteucci et al. Frontiers in Oncology
- Digital PET/CT allows for shorter acquisition protocols or reduced radiopharmaceutical dose in [18F]-FDG PET/CT
- (2021) Ian Alberts et al. ANNALS OF NUCLEAR MEDICINE
- End-of-treatment PET/CT predicts PFS and OS in DLBCL after first-line treatment: results from GOYA
- (2021) Lale Kostakoglu et al. Blood Advances
- FDG PET/CT to detect bone marrow involvement in the initial staging of patients with aggressive non-Hodgkin lymphoma: results from the prospective, multicenter PETAL and OPTIMAL>60 trials
- (2021) Dominic Kaddu-Mulindwa et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Artificial intelligence could alert for focal skeleton/bone marrow uptake in Hodgkin’s lymphoma patients staged with FDG-PET/CT
- (2021) May Sadik et al. Scientific Reports
- Interim and end‐of‐treatment PET‐CT suffers from high false‐positive rates in DLBCL: Biopsy is needed prior to treatment decisions
- (2021) Susanna Tokola et al. Cancer Medicine
- Comparison of [18F]FDG PET/CT and MRI for Treatment Response Assessment in Multiple Myeloma: A Meta-Analysis
- (2021) Kota Yokoyama et al. Diagnostics
- Total metabolic tumor volume as a survival predictor for patients with diffuse large B-cell lymphoma in the GOYA study
- (2021) Lale Kostakoglu et al. HAEMATOLOGICA
- Whole-Body Magnetic Resonance Imaging: Current Role in Patients with Lymphoma
- (2021) Domenico Albano et al. Diagnostics
- Comparative Performance of Whole Body MRI and 18F-FDG PET/CT in Evaluation of Response to Treatment of Multiple Myeloma: Meta-analysis and Systematic Review
- (2021) Sharath Rama et al. AMERICAN JOURNAL OF ROENTGENOLOGY
- Response-Adapted Postinduction Strategy in Patients With Advanced-Stage Follicular Lymphoma: The FOLL12 Study
- (2021) Stefano Luminari et al. JOURNAL OF CLINICAL ONCOLOGY
- Radiation Dose Modulation of Computed Tomography Component in Positron Emission Tomography/Computed Tomography
- (2021) Yusuke Inoue SEMINARS IN NUCLEAR MEDICINE
- Current Role of Functional Imaging in the Management of Lymphoma
- (2021) Bruce D. Cheson et al. Current Oncology Reports
- Diagnostic value of baseline 18FDG PET/CT skeletal textural features in follicular lymphoma
- (2021) Julie Faudemer et al. Scientific Reports
- Uncommon Variants of Mature T-Cell Lymphomas (MTCLs): Imaging and Histopathologic and Clinical Features with Updates from the Fourth Edition of the World Health Organization (WHO) Classification of Lymphoid Neoplasms
- (2021) Ahmed Ebada Salem et al. Cancers
- An Overview of Selected Rare B-Cell Lymphoproliferative Disorders: Imaging, Histopathologic, and Clinical Features
- (2021) Ahmed Ebada Salem et al. Cancers
- High total metabolic tumor volume at baseline allows discrimination of survival even in patients aged 60 to 80 years responding to R-CHOP
- (2020) Laetitia Vercellino et al. BLOOD
- FDG-PET Imaging for Hodgkin and Diffuse Large B-Cell Lymphoma—An Updated Overview
- (2020) Conrad-Amadeus Voltin et al. Cancers
- CT protocol optimisation in PET/CT: a systematic review
- (2020) V. Bertolini et al. EJNMMI Physics
- Prognostic Value of 18F-FDG PET/CT Metabolic Parameters in Splenic Marginal Zone Lymphoma
- (2020) Domenico Albano et al. Clinical Lymphoma Myeloma & Leukemia
- High metabolic heterogeneity on baseline 18FDG-PET/CT scan as a poor prognostic factor for newly diagnosed diffuse large B-cell lymphoma
- (2020) Hajime Senjo et al. Blood Advances
- Long-Term Results of PET-Guided Radiation in Advanced-Stage Diffuse Large B-Cell Lymphoma Patients Treated with R-CHOP
- (2020) Ciara L. Freeman et al. BLOOD
- Classical Hodgkin Lymphoma: Clinicopathologic Features, Prognostic Factors, and Outcomes From a 28-Year Single Institutional Experience
- (2020) Ashley Rose et al. Clinical Lymphoma Myeloma & Leukemia
- Consolidation Radiotherapy Could Be Safely Omitted in Advanced Hodgkin Lymphoma With Large Nodal Mass in Complete Metabolic Response After ABVD: Final Analysis of the Randomized GITIL/FIL HD0607 Trial
- (2020) Andrea Gallamini et al. JOURNAL OF CLINICAL ONCOLOGY
- Glucose Metabolism Quantified by SUVmax on Baseline FDG-PET/CT Predicts Survival in Newly Diagnosed Multiple Myeloma Patients: Combined Harmonized Analysis of Two Prospective Phase III Trials
- (2020) Anne-Victoire Michaud-Robert et al. Cancers
- Risk stratification in diffuse large B-cell lymphoma using lesion dissemination and metabolic tumor burden calculated from baseline PET/CT†
- (2020) A.-S. Cottereau et al. ANNALS OF ONCOLOGY
- Standardization of 18F-FDG–PET/CT According to Deauville Criteria for Metabolic Complete Response Definition in Newly Diagnosed Multiple Myeloma
- (2020) Elena Zamagni et al. JOURNAL OF CLINICAL ONCOLOGY
- Age-related changes of standardized uptake values in the blood pool and liver: a decade-long retrospective study of the outcomes of 2,526 subjects
- (2020) Yuan Cao et al. Quantitative Imaging in Medicine and Surgery
- FDG PET/CT as a diagnostic and prognostic tool for the evaluation of marginal zone lymphoma
- (2019) Iuliana Vaxman et al. HEMATOLOGICAL ONCOLOGY
- Positron Emission Tomography Score Has Greater Prognostic Significance Than Pretreatment Risk Stratification in Early-Stage Hodgkin Lymphoma in the UK RAPID Study
- (2019) Sally F. Barrington et al. JOURNAL OF CLINICAL ONCOLOGY
- Imaging of Waldenström Macroglobulinemia: A Comprehensive Review for the Radiologist in the Era of Personalized Medicine
- (2019) Richard Thomas et al. AMERICAN JOURNAL OF ROENTGENOLOGY
- MRI and PET/MRI in hematologic malignancies
- (2019) Marius E. Mayerhoefer et al. JOURNAL OF MAGNETIC RESONANCE IMAGING
- 18F-FDG-PET dissemination features in diffuse large B cell lymphoma are prognostic of outcome
- (2019) Anne-Segolene Cottereau et al. JOURNAL OF NUCLEAR MEDICINE
- Utility of FDG-PET/CT in Lymphoblastic Lymphoma
- (2019) Thomas A Fox et al. BLOOD
- The rapidly changing landscape in mature T‐cell lymphoma (MTCL) biology and management
- (2019) Enrica Marchi et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Metabolic heterogeneity on baseline 18FDG-PET/CT scan is a predictor of outcome in primary mediastinal B-cell lymphoma
- (2018) Luca Ceriani et al. BLOOD
- Positron Emission Tomography–Guided Therapy of Aggressive Non-Hodgkin Lymphomas (PETAL): A Multicenter, Randomized Phase III Trial
- (2018) Ulrich Dührsen et al. JOURNAL OF CLINICAL ONCOLOGY
- FDG-PET/CT in the management of lymphomas: Current status and future directions
- (2018) Tarec Christoffer El-Galaly et al. JOURNAL OF INTERNAL MEDICINE
- Brentuximab Vedotin with Chemotherapy for Stage III or IV Hodgkin’s Lymphoma
- (2018) Joseph M. Connors et al. NEW ENGLAND JOURNAL OF MEDICINE
- [18F]FDG-PET/CT in Hodgkin Lymphoma: Current Usefulness and Perspectives
- (2018) Salim Kanoun et al. Cancers
- Imaging features (CT, MRI, MRS, and PET/CT) of primary central nervous system lymphoma in immunocompetent patients
- (2018) Gang Cheng et al. NEUROLOGICAL SCIENCES
- FDG PET for therapy monitoring in Hodgkin and non-Hodgkin lymphomas
- (2017) Sally F. Barrington et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Early Positron Emission Tomography Response–Adapted Treatment in Stage I and II Hodgkin Lymphoma: Final Results of the Randomized EORTC/LYSA/FIL H10 Trial
- (2017) Marc P.E. André et al. JOURNAL OF CLINICAL ONCOLOGY
- Prognostic significance of total metabolic tumor volume on 18F-fluorodeoxyglucose positron emission tomography/ computed tomography in patients with diffuse large B-cell lymphoma receiving rituximab-containing chemotherapy
- (2017) Chin-Chuan Chang et al. Oncotarget
- Effective dose estimation for oncological and neurological PET/CT procedures
- (2017) Josep M. Martí-Climent et al. EJNMMI Research
- Refinement of the Lugano Classification lymphoma response criteria in the era of immunomodulatory therapy
- (2016) Bruce D. Cheson et al. BLOOD
- The 2016 revision of the World Health Organization classification of lymphoid neoplasms
- (2016) S. H. Swerdlow et al. BLOOD
- FDG-PET imaging in hematological malignancies
- (2016) L. Valls et al. BLOOD REVIEWS
- Proportion of false-positive lesions at interim and end-of-treatment FDG-PET in lymphoma as determined by histology: Systematic review and meta-analysis
- (2016) Hugo J.A. Adams et al. EUROPEAN JOURNAL OF RADIOLOGY
- Adapted Treatment Guided by Interim PET-CT Scan in Advanced Hodgkin’s Lymphoma
- (2016) Peter Johnson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Lymphoma
- (2016) Emiliano N. Mugnaini et al. PRIMARY CARE
- Radiation dosimetry of 18F-FDG PET/CT: incorporating exam-specific parameters in dose estimates
- (2016) Brian Quinn et al. BMC MEDICAL IMAGING
- For avid glucose tumors, the SUV peak is the most reliable parameter for [18F]FDG-PET/CT quantification, regardless of acquisition time
- (2016) Avigaëlle Sher et al. EJNMMI Research
- Results of a Trial of PET-Directed Therapy for Early-Stage Hodgkin’s Lymphoma
- (2015) John Radford et al. NEW ENGLAND JOURNAL OF MEDICINE
- Imaging for Staging and Response Assessment in Lymphoma
- (2015) Sarah A. Johnson et al. RADIOLOGY
- The prognostic role of post-induction FDG-PET in patients with follicular lymphoma: a subset analysis from the FOLL05 trial of the Fondazione Italiana Linfomi (FIL)
- (2014) S. Luminari et al. ANNALS OF ONCOLOGY
- FDG PET-CT in follicular lymphoma: a case-based evidence review
- (2014) S. D. Smith et al. BLOOD
- Characterizing bone marrow involvement in Hodgkin’s lymphoma by FDG-PET/CT
- (2014) Michal Weiler-Sagie et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- FDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.0
- (2014) Ronald Boellaard et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- The importance of harmonizing interim positron emission tomography in non-Hodgkin lymphoma: focus on the Deauville criteria
- (2014) E. Quak et al. HAEMATOLOGICA
- The predictive role of interim positron emission tomography for Hodgkin lymphoma treatment outcome is confirmed using the interpretation criteria of the Deauville five-point scale
- (2014) A. Gallamini et al. HAEMATOLOGICA
- Significant Contribution of Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography (FDG PET/CT) in a Case of Acute Lymphoblastic Leukemia Presenting with Fever of Unknown Origin
- (2014) Ferhat Arslan et al. INTERNAL MEDICINE
- Role of Imaging in the Staging and Response Assessment of Lymphoma: Consensus of the International Conference on Malignant Lymphomas Imaging Working Group
- (2014) Sally F. Barrington et al. JOURNAL OF CLINICAL ONCOLOGY
- Recommendations for Initial Evaluation, Staging, and Response Assessment of Hodgkin and Non-Hodgkin Lymphoma: The Lugano Classification
- (2014) Bruce D. Cheson et al. JOURNAL OF CLINICAL ONCOLOGY
- Prognostic value of PET-CT after first-line therapy in patients with follicular lymphoma: a pooled analysis of central scan review in three multicentre studies
- (2014) Judith Trotman et al. Lancet Haematology
- Evolving Role of FDG PET/CT in Multiple Myeloma Imaging and Management
- (2013) Ankit Agarwal et al. AMERICAN JOURNAL OF ROENTGENOLOGY
- The use of FDG-PET in the initial staging of 142 patients with follicular lymphoma: a retrospective study from the FOLL05 randomized trial of the Fondazione Italiana Linfomi
- (2013) S. Luminari et al. ANNALS OF ONCOLOGY
- Report on the 4th International Workshop on Positron Emission Tomography in Lymphoma held in Menton, France, 3–5 October 2012
- (2013) Michel Meignan et al. LEUKEMIA & LYMPHOMA
- Routine Bone Marrow Biopsy Has Little or No Therapeutic Consequence for Positron Emission Tomography/Computed Tomography–Staged Treatment-Naive Patients With Hodgkin Lymphoma
- (2012) Tarec Christoffer El-Galaly et al. JOURNAL OF CLINICAL ONCOLOGY
- Heterogeneous spectrum of neuropathies in Waldenström's macroglobulinemia: a diagnostic strategy to optimize their management
- (2012) Karine Viala et al. JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM
- Reduced-intensity chemotherapy and PET-guided radiotherapy in patients with advanced stage Hodgkin's lymphoma (HD15 trial): a randomised, open-label, phase 3 non-inferiority trial
- (2012) Andreas Engert et al. LANCET
- Prognostic significance of interim 18F-FDG PET/CT after three or four cycles of R-CHOP chemotherapy in the treatment of diffuse large B-cell lymphoma
- (2011) Deok-Hwan Yang et al. EUROPEAN JOURNAL OF CANCER
- Positron Emission Tomography–Computed Tomography (PET-CT) After Induction Therapy Is Highly Predictive of Patient Outcome in Follicular Lymphoma: Analysis of PET-CT in a Subset of PRIMA Trial Participants
- (2011) Judith Trotman et al. JOURNAL OF CLINICAL ONCOLOGY
- Role of Functional Imaging in the Management of Lymphoma
- (2011) Bruce D. Cheson JOURNAL OF CLINICAL ONCOLOGY
- The value of FDG PET/CT in the initial staging and bone marrow involvement of patients with multiple myeloma
- (2011) Sait Sager et al. SKELETAL RADIOLOGY
- Extranodal manifestations of lymphoma on [18F]FDG-PET/CT: a pictorial essay
- (2011) R. Kashyap et al. CANCER IMAGING
- A Systematic Review of the Factors Affecting Accuracy of SUV Measurements
- (2010) Michael C. Adams et al. AMERICAN JOURNAL OF ROENTGENOLOGY
- Follicular non-Hodgkin's lymphoma
- (2010) D. Hayashi et al. CLINICAL RADIOLOGY
- Prognostic impact of 18F-fluoro-deoxyglucose positron emission tomography in untreated mantle cell lymphoma: a retrospective study from the GOELAMS group
- (2010) Caroline Bodet-Milin et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Time-of-flight PET/CT using low-activity protocols: potential implications for cancer therapy monitoring
- (2010) Iain Murray et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Risk-Adapted Dose-Dense Immunochemotherapy Determined by Interim FDG-PET in Advanced-Stage Diffuse Large B-Cell Lymphoma
- (2010) Craig H. Moskowitz et al. JOURNAL OF CLINICAL ONCOLOGY
- Multiple myeloma
- (2010) Conor D. Collins CANCER IMAGING
- Role of radiography, MRI and FDG-PET/CT in diagnosing, staging and therapeutical evaluation of patients with multiple myeloma
- (2009) Susanne Lütje et al. ANNALS OF HEMATOLOGY
- The majority of transformed lymphomas have high standardized uptake values (SUVs) on positron emission tomography (PET) scanning similar to diffuse large B-cell lymphoma (DLBCL)
- (2009) A. Noy et al. ANNALS OF ONCOLOGY
- High SUV uptake on FDG-PET/CT predicts for an aggressive B-cell lymphoma in a prospective study of primary FDG-PET/CT staging in lymphoma
- (2009) J. Y. Y. Ngeow et al. ANNALS OF ONCOLOGY
- Prediction of Progression-Free Survival in Patients With Multiple Myeloma Following Anthracycline-Based Chemotherapy Based on Dynamic FDG-PET
- (2009) Antonia Dimitrakopoulou-Strauss et al. CLINICAL NUCLEAR MEDICINE
- International myeloma working group consensus statement and guidelines regarding the current role of imaging techniques in the diagnosis and monitoring of multiple Myeloma
- (2009) M Dimopoulos et al. LEUKEMIA
- Report on the First International Workshop on interim-PET scan in lymphoma
- (2009) Michel Meignan et al. LEUKEMIA & LYMPHOMA
- Molecular subtypes of diffuse large B-cell lymphoma arise by distinct genetic pathways
- (2008) G. Lenz et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Highly Iodinated Intravenous Contrast Material for PET/CT – a Feasibility Study
- (2008) T Heusner et al. ROFO-FORTSCHRITTE AUF DEM GEBIET DER RONTGENSTRAHLEN UND DER BILDGEBENDEN VERFAHREN
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now